COL15A1 and neoplasm: Tumour cell proliferation analyses with two different antibodies showed a trend towards higher proliferation in early-stage PyMT;Col15a1−/− tumours collected from mice at the ages of 6–9 weeks than in controls of the same stage, but lower proliferation in late-stage tumours at weeks 10–14.